On January 16, the Executive Office and Ho Chi Minh City Branch held a Conference to implement the 2023 Business Plan.

In 2022, the world economic situation had many complicated changes such as a sharp increase in the prices of energy, goods and input materials, disruption of supply chains, high inflation in many countries, conflict between Russia and Ukraine, affecting the recovery of the world economy after more than 2 years of being heavily affected by the Covid-19 pandemic. And this has greatly affected the Vietnamese economy. Many businesses face difficulties in maintaining business operations.

However, with an effective, flexible business strategy and timely solutions, as well as the consensus and solidarity of efforts of all employees, Bepharco Group has successfully completed the plan of the General Meeting of Shareholders. proposed, continuing to affirm its position as a leading enterprise in the pharmaceutical industry.
Speaking at the Conference, Mr. Nguyen Khac Hanh - Vice General Director highly appreciated the results of business activities in 2022, and clearly defined the tasks and goals of the plan in 2023. Mr. Hoang Xuan An - Vice General Director, praised the Company's achievements in 2022 and pointed out the limitations that need to be overcome to develop more effectively and sustainably.

After the Business Plan Implementation Conference, Bepharco Group organized a Year End Party for all employees at the Executive Office and Ho Chi Minh City Branch. Mr.Pham Thu Trieu - General Director honored, rewarded and recognized the efforts of the collectives and individuals that have successfully completed the assigned tasks in 2022, also sent New Year wishes for success, happiness and love.

The year 2023 marks the 60th anniversary of establishment, the Board Of Management and the Board of General Directors wish to bring Bepharco into the Top 5 leading pharmaceutical companies in Vietnam and gradually reach the international level.